|
Market Closed -
Bombay S.E.
11:02:28 01/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 596.10 INR | -4.19% |
|
-8.90% | +35.94% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
| Market Cap | 1.32B 13.95M 12.03M 11.32M 10.31M 19.39M 19.49M 134M 52.08M 673M 52.37M 51.24M 2.23B | P/E 2024 |
8.4x | P/E 2025 | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 1.05B 11.06M 9.54M 8.98M 8.18M 15.38M 15.46M 106M 41.3M 534M 41.54M 40.64M 1.77B | EV / Sales 2024 |
1.25x | EV / Sales 2025 | 1.94x |
| Free-Float |
19.97% | Yield 2024 |
0.54% | Yield 2025 | 0.21% |
| 1 day | -4.19% | ||
| 1 week | -8.90% | ||
| Current month | -4.19% | ||
| 1 month | +3.79% | ||
| 3 months | +26.01% | ||
| 6 months | +34.35% | ||
| Current year | +35.94% |
| 1 week | 592.4 |  | 663.2 |
| 1 month | 540 | | 679 |
| Current year | 360 | | 679 |
| 1 year | 360 | | 679 |
| 3 years | 262 | | 999 |
| 5 years | 217 | | 999 |
| 10 years | 81.2 | | 1,190 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 25/05/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 45 | 25/05/2017 | |
| Director/Board Member | 49 | 25/05/2017 | |
Saurabh Shah
BRD | Director/Board Member | 40 | 27/05/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.19% | -8.90% | +33.65% | +118.63% | 23.36M | |
| +0.14% | -6.05% | +57.65% | +108.04% | 1,031B | |
| +1.88% | -0.98% | +51.89% | +68.53% | 641B | |
| +1.30% | -2.28% | +22.57% | +75.26% | 453B | |
| -1.50% | -7.04% | +33.55% | +33.94% | 349B | |
| +6.25% | +2.04% | +28.97% | +46.57% | 290B | |
| -0.07% | -4.12% | +0.95% | +11.79% | 252B | |
| +1.54% | -1.42% | +51.95% | +69.83% | 232B | |
| +0.51% | -4.52% | -19.50% | -54.83% | 201B | |
| +1.96% | +0.05% | +32.06% | +94.18% | 181B | |
| Average | +0.68% | -3.17% | +29.37% | +57.19% | 362.98B | |
| Weighted average by Cap. | +1.02% | -3.97% | +37.80% | +66.12% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 837M 8.82M 7.6M 7.15M 6.52M 12.25M 12.32M 84.56M 32.91M 426M 33.1M 32.38M 1.41B | 1.15B 12.12M 10.45M 9.83M 8.96M 16.84M 16.94M 116M 45.24M 585M 45.5M 44.51M 1.94B |
| Net income | 158M 1.66M 1.44M 1.35M 1.23M 2.31M 2.33M 15.96M 6.21M 80.32M 6.25M 6.11M 266M | 242M 2.55M 2.2M 2.07M 1.88M 3.54M 3.56M 24.41M 9.5M 123M 9.56M 9.35M 407M |
| Net Debt | -278M -2.93M -2.53M -2.38M -2.16M -4.07M -4.09M -28.08M -10.93M -141M -10.99M -10.75M -469M | -274M -2.89M -2.49M -2.34M -2.13M -4.01M -4.03M -27.68M -10.77M -139M -10.84M -10.6M -462M |
Employees
197
Sector
Pharmaceuticals
Calendar
09-22
Ex-dividend date - 2 INR
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | ₹596.10 | -4.19% | 2,363 |
| 31/08/26 | ₹622.15 | -3.27% | 1,914 |
| 28/08/26 | ₹643.15 | +0.77% | 791 |
| 27/08/26 | ₹638.25 | -1.05% | 553 |
| 26/08/26 | ₹645.00 | +0.36% | 725 |
- Stock Market
- Stocks
- CORALAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
